RxDoctor Payments DataLook up a doctor →

Julio Ramirez

Infectious Disease · Louisville, KYNPI 1225016983

Payments from drug & device makers

$18,627,539in general payments, 2019–2025

Across 463 payments — averaging $40,232 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$17.7M
  • Janssen Research & Development, LLC$530K
  • Sanofi Pasteur Inc.$188K
  • Eli Lilly$115K
  • Paratek Pharmaceuticals, Inc.$26K
  • Pfizer Chile S.A.$21K
  • plus $40K from 17 others
$175,540in research payments, 2019–2025

Across 7 payments — averaging $25,077 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$168K
  • Pfizer$8K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$18,627,539 in reported general payments places this provider in the 95th percentile of 100 infectious disease providers in Kentucky.

See all infectious disease providers in Kentucky

Other infectious disease in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →